Segment Information (Tables)
|
12 Months Ended |
Jun. 30, 2026 |
| Segment Reporting [Abstract] |
|
| Segment Reporting [Table Text Block] |
|
| Revenue by Reportable Segment |
The following table presents revenue for the two reportable segments and disaggregated revenue within the remaining operating segments, included in Other, and Corporate: | | | | | | | | | | | | | | | | | | | (in millions) | 2026 | | 2025 | | 2024 | | Pharmaceutical and Specialty Solutions | $ | 234,833 | | | $ | 204,644 | | | $ | 210,019 | | | Global Medical Products and Distribution | 12,719 | | | 12,636 | | | 12,381 | | | Nuclear and Precision Health Solutions | 1,851 | | | 1,578 | | | 1,369 | | | at-Home Solutions | 4,536 | | | 3,480 | | | 2,869 | | OptiFreight® Logistics | 405 | | | 324 | | | 274 | | | Other | 6,792 | | | 5,382 | | | 4,512 | | | Total segment revenue | 254,344 | | | 222,662 | | | 226,912 | | Corporate (1) | (96) | | | (84) | | | (85) | | | Total revenue | $ | 254,248 | | | $ | 222,578 | | | $ | 226,827 | |
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
|
| Disaggregation of Revenue [Table Text Block] |
| | | | | | | | | | | | | | | | | | | (in millions) | 2026 | | 2025 | | 2024 | | Pharmaceutical and Specialty Solutions | $ | 234,833 | | | $ | 204,644 | | | $ | 210,019 | | | Global Medical Products and Distribution | 12,719 | | | 12,636 | | | 12,381 | | | Nuclear and Precision Health Solutions | 1,851 | | | 1,578 | | | 1,369 | | | at-Home Solutions | 4,536 | | | 3,480 | | | 2,869 | | OptiFreight® Logistics | 405 | | | 324 | | | 274 | | | Other | 6,792 | | | 5,382 | | | 4,512 | | | Total segment revenue | 254,344 | | | 222,662 | | | 226,912 | | Corporate (1) | (96) | | | (84) | | | (85) | | | Total revenue | $ | 254,248 | | | $ | 222,578 | | | $ | 226,827 | |
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
|
| Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue [Table Text Block] |
The following table presents revenue by geographic area: | | | | | | | | | | | | | | | | | | | (in millions) | 2026 | | 2025 | | 2024 | | United States | $ | 252,639 | | | $ | 220,993 | | | $ | 225,231 | | | International | 1,705 | | | 1,669 | | | 1,681 | | | Total segment revenue | 254,344 | | | 222,662 | | | 226,912 | | Corporate (1) | (96) | | | (84) | | | (85) | | | Total revenue | $ | 254,248 | | | $ | 222,578 | | | $ | 226,827 | |
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
|
| Segment Profit by Reportable Segment |
The following tables present revenue, expenses, and segment profit for the two reportable segments and the remaining operating segments, included in Other, and Corporate: | | | | | | | | | | | | | | | | | | | | | | | | | 2026 | | (in millions) | Pharma | | GMPD | | Other | | Total | Segment revenue | $ | 234,833 | | | $ | 12,719 | | | $ | 6,792 | | | $ | 254,344 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Cost of products sold | 229,141 | | | 10,383 | | | 5,044 | | | 244,568 | | | SG&A | 2,909 | | | 2,078 | | | 1,041 | | | 6,028 | | Total segment expenses | 232,050 | | | 12,461 | | | 6,085 | | | 250,596 | | | | | | | | | | | Segment profit | $ | 2,783 | | | $ | 258 | | | $ | 707 | | | $ | 3,748 | | Corporate (1) | | | | | | | (1,135) | | | Consolidated operating earnings | | | | | | $ | 2,613 | |
| | | | | | | | | | | | | | | | | | | | | | | | | 2025 | | (in millions) | Pharma | | GMPD | | Other | | Total | Segment revenue | $ | 204,644 | | | $ | 12,636 | | | $ | 5,382 | | | $ | 222,662 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Cost of products sold | 199,999 | | | 10,470 | | | 4,023 | | | 214,492 | | | SG&A | 2,387 | | | 2,031 | | | 843 | | | 5,261 | | Total segment expenses | 202,386 | | | 12,501 | | | 4,866 | | | 219,753 | | | | | | | | | | | Segment profit | $ | 2,258 | | | $ | 135 | | | $ | 516 | | | $ | 2,909 | | Corporate (1) | | | | | | | (634) | | | Consolidated operating earnings | | | | | | $ | 2,275 | |
| | | | | | | | | | | | | | | | | | | | | | | | | 2024 | | (in millions) | Pharma | | GMPD | | Other | | Total | | Segment revenue | $ | 210,019 | | | $ | 12,381 | | | $ | 4,512 | | | $ | 226,912 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Cost of products sold | 205,864 | | | 10,264 | | | 3,367 | | | 219,495 | | | SG&A | 2,140 | | | 2,025 | | | 722 | | | 4,887 | | | Total segment expenses | 208,004 | | | 12,289 | | | 4,089 | | | 224,382 | | | | | | | | | | | Segment profit | $ | 2,015 | | | $ | 92 | | | $ | 423 | | | $ | 2,530 | | Corporate (1) | | | | | | | (1,287) | | | Consolidated operating earnings | | | | | | $ | 1,243 | |
(1)Corporate revenue and expenses consists of the elimination of inter-segment revenue and other revenue and expenses not allocated to the segments.
|
| Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment |
| | | | | | | | | | | | | | | | | | | (in millions) | 2026 | | 2025 | | 2024 | | Pharmaceutical and Specialty Solutions | $ | 257 | | | $ | 185 | | | $ | 184 | | | Global Medical Products and Distribution | 219 | | | 212 | | | 205 | | | Other | 112 | | | 88 | | | 79 | | | Corporate | 368 | | | 305 | | | 242 | | | Total depreciation and amortization | $ | 956 | | | $ | 790 | | | $ | 710 | |
| | | | | | | | | | | | | | | | | | | (in millions) | 2026 | | 2025 | | 2024 | | Pharmaceutical and Specialty Solutions | $ | 160 | | | $ | 118 | | | $ | 76 | | | Global Medical Products and Distribution | 134 | | | 133 | | | 136 | | | Other | 111 | | | 88 | | | 81 | | | Corporate | 244 | | | 208 | | | 218 | | | Total additions to property and equipment | $ | 649 | | | $ | 547 | | | $ | 511 | |
|
| Assets by Reportable Segment |
|
| Property and Equipment, Net by Geographic Area |
The following table presents property and equipment, net by geographic area at June 30: | | | | | | | | | | | | | | | (in millions) | 2026 | | 2025 | | | | United States | $ | 2,607 | | | $ | 2,422 | | | | | International | 424 | | | 436 | | | | | Property and equipment, net | $ | 3,031 | | | $ | 2,858 | | | |
|